CryoLife Inc. (NYSE:CRY) said yesterday that it closed its play for the mechanical heart valve space, the $130 million acquisition of On-X Life Technologies. On-X makes an aortic valve replacement and is developing a mitral chord repair device called Chord-X. The Austin, Texas-based company put up sales of about $33 million last year. The deal called for [...]The post CryoLife closes $130m On-X Technologies buyout appeared first on MassDevice.